全文获取类型
收费全文 | 1474篇 |
免费 | 86篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 80篇 |
妇产科学 | 17篇 |
基础医学 | 192篇 |
口腔科学 | 29篇 |
临床医学 | 128篇 |
内科学 | 391篇 |
皮肤病学 | 43篇 |
神经病学 | 44篇 |
特种医学 | 121篇 |
外科学 | 104篇 |
综合类 | 86篇 |
一般理论 | 1篇 |
预防医学 | 87篇 |
眼科学 | 28篇 |
药学 | 122篇 |
中国医学 | 12篇 |
肿瘤学 | 85篇 |
出版年
2023年 | 9篇 |
2021年 | 19篇 |
2020年 | 23篇 |
2019年 | 17篇 |
2018年 | 24篇 |
2017年 | 11篇 |
2016年 | 22篇 |
2015年 | 32篇 |
2014年 | 36篇 |
2013年 | 46篇 |
2012年 | 63篇 |
2011年 | 66篇 |
2010年 | 60篇 |
2009年 | 33篇 |
2008年 | 55篇 |
2007年 | 48篇 |
2006年 | 51篇 |
2005年 | 34篇 |
2004年 | 32篇 |
2003年 | 33篇 |
2002年 | 32篇 |
2001年 | 35篇 |
2000年 | 25篇 |
1999年 | 37篇 |
1998年 | 34篇 |
1997年 | 28篇 |
1996年 | 41篇 |
1995年 | 24篇 |
1994年 | 19篇 |
1993年 | 23篇 |
1992年 | 38篇 |
1991年 | 34篇 |
1990年 | 31篇 |
1989年 | 52篇 |
1988年 | 53篇 |
1987年 | 39篇 |
1986年 | 34篇 |
1985年 | 30篇 |
1984年 | 28篇 |
1983年 | 24篇 |
1982年 | 13篇 |
1981年 | 16篇 |
1980年 | 12篇 |
1979年 | 18篇 |
1978年 | 16篇 |
1977年 | 16篇 |
1976年 | 15篇 |
1975年 | 18篇 |
1973年 | 10篇 |
1972年 | 9篇 |
排序方式: 共有1574条查询结果,搜索用时 31 毫秒
1.
新生儿远程医疗 总被引:1,自引:1,他引:0
Abhishek Makkar R Michael Siatkowski Edgardo Szyl Abhrajit Ganguly Kris Sekar 《中国当代儿科杂志》2020,22(5):396-408
正医生短缺是一个世界性的问题。最近,世界卫生组织(WHO)报告全球短缺430万名医生、护士和其他卫生保健专业人员。在发展中国家,由于医学院的数量和能力有限,这种短缺更加严重。包括美国、加拿大、新西兰、英国、澳大利亚和德国在内的许多发达国家都报告了类似的问题~([1])。美国医学院协会估计,到2032年,美国医生缺口将达到46 900~121 900人~([2])。医生短缺将导致城市和农村地区都得不到足够的医疗。目前,城市地区每万名居民医生的数量是农村地区的两倍。在亚专科医 相似文献
2.
Ian RP Sunderland Glenn Edwards James Mainprize Oleh Antonyshyn 《CANADIAN JOURNAL OF PLASTIC SURGERY》2015,23(2):95-99
Prefabricated, patient-specific alloplastic implants for cranioplasty reduce surgical complexity, decrease operative times, minimize exposure and risk of contamination, and have resulted in improved aesthetic results. However, in creating a prefabricated custom implant using a patient’s computed tomography data, a stable, unalterable defect must be clearly defined before surgery. In the event that an intraoperative modification of an exiting skull defect is required, or in cases of tumour resection in which the size of the skull defect is unknown preoperatively, these prefabricated implants cannot be used. The ideal method for alloplastic cranioplasty would enable cost-effective creation of a patient-specific implant with the capacity for intraoperative modification.The present article describes a novel technique of cranioplasty that uses a patient’s computed tomography data to create a custom forming tool (ie, mold), enabling intraoperative creation of a patient-specific titanium mesh implant. The utility of these implants in creating a custom reconstructive solution in cases in which the size of the skull defect is unknown preoperatively will be demonstrated using two case presentations. 相似文献
3.
4.
Mohammed S. Al-Marhoon Allal Ouhtit Aisha O. Al-Abri Krishna P. Venkiteswaran Qassim Al-Busaidi Josephkunju Mathew Ibrahim Al-Haddabi Omar Shareef Shahid Aquil Khalid Rahman Intisar Al-Hashmi Ishita Gupta Shyam S. Ganguly 《Current Urology》2015,8(3):138-143
Objectives
To determine whether Helicobacter pylori (H. pylori) is detectable in both benign prostatic hyperplasia (BPH) and prostate cancer (PCa). Epidemiological studies have shown significant associations between infective chronic prostatitis and prostatic carcinoma. Many bacteria have been found in the prostate of patients with chronic prostatitis, BPH, and PCa.Methods
One hundred consecutive patients with prostate diseases were enrolled in the study. Detection of H. pylori DNA in prostate tissue from patients with BPH and PCa was performed using both immunohistochemistry and PCR, and the results were confirmed by DNA sequencing. Odds ratios and the Fisher Exact test were used for the analysis of the associations between the variables.Results
Among the patients, 78% had BPH and 19% had PCa. While immunohistochemistry showed no positive sample for H. pylori, PCR combined with sequencing detected H. pylori DNA in prostate tissue samples from 5 patients. However, statistical analysis of the data showed that BPH and PCa are not significantly associated with the presence of H. pylori DNA in prostate tissue (odds ratio = 0.94, 95% confidence interval = 0.09–23.34, one-tailed Chi-square value = 0.660, p > 0.05). The limitation of this study was the small number of PCa patients.Conclusions
This study provides, for the first time, molecular evidence of the presence of H. pylori DNA in prostatic tissue of patients with BPH and PCa. It paves the way for further comprehensive studies to examine the association of H. pylori infection with BPH and PCa.Key Words: Helicobacter pylori infection, Prostate cancer, Benign prostate hyperplasia, PCR 相似文献5.
6.
Sarkar S Sett P Chowdhury T Ganguly DK 《Journal of the Indian Society of Pedodontics and Preventive Dentistry》2000,18(4):139-140
Dental caries is the prime cause of premature loss of teeth in children. Tea contains high percentage of fluoride along with polyphenolic constituents which act on GTF of S. mutans in plaque synthesis. Combination of fluoride and polyphenolic constituents inhibit caries activity. 相似文献
7.
8.
Emma C. Scott Parameswaran Hari Sathish Kumar Raphael Fraser Omar Davila Nina Shah Robert Peter Gale Miguel Angel Diaz Vaibhav Agrawal Robert F. Cornell Siddhartha Ganguly Gorgun Akpek Cesar Freytes Shahrukh Hashmi Ehsan Malek Rammurti T. Kamble Hillard Lazarus Melhem Solh Anita DSouza 《Biology of blood and marrow transplantation》2018,24(12):2443-2449
The Revised International Staging System (R-ISS) and the International Myeloma Working Group 2014 (IMWG 2014) are newer staging systems used to prognosticate multiple myeloma (MM) outcomes. We hypothesized that these would provide better prognostic differentiation for newly diagnosed multiple myeloma (MM) compared with ISS. We analyzed the Center for International Blood and Marrow Transplant Research database from 2008 to 2014 to compare the 3 systems (N?=?628) among newly diagnosed MM patients undergoing upfront autologous hematopoietic cell transplantation (AHCT). The median follow-up of survivors was 48 (range, 3 to 99) months. The R-ISS provided the greatest differentiation between survival curves for each stage (for overall survival [OS], the differentiation was 1.74 using the R-ISS, 1.58 using ISS, and 1.60 using the IMWG 2014) . Univariate analyses at 3 years for OS showed R-ISS I at 88% (95% confidence interval [CI], 83% to 93%), II at 75% (95% CI, 70% to 80%), and III at 56% (95% CI, 3% to 69%; P < .001). An integrated Brier score function demonstrated the R-ISS had the best prediction for PFS, though all systems had similar prediction for OS. Among available systems, the R-ISS is the most optimal among available prognostic tools for newly diagnosed MM undergoing AHCT. We recommend that serum lactate dehydrogenase and cytogenetic data be performed on every MM patient at diagnosis to allow accurate prognostication. 相似文献
9.
David F. Stroncek Bronwen E. Shaw Brent R. Logan Deidre M. Kiefer Bipin N. Savani Paolo Anderlini Christopher N. Bredeson Peiman Hematti Siddhartha Ganguly Miguel Angel Diaz Hisham Abdel-Azim Ibrahim Ahmed Dipnarine Maharaj Matthew Seftel Amer Beitinjaneh Sachiko Seo Jean A. Yared Joerg Halter Michael A. Pulsipher 《Biology of blood and marrow transplantation》2018,24(1):175-184
Little is known about the experiences of individuals donating peripheral blood stem cells (PBSCs) or marrow for a second time. To study this, unrelated donors making a second donation through the National Marrow Donor Program between 2004 and 2013 were evaluated. Experiences of second-time donors giving marrow (n?=?118: first donation was PBSC in 76 and marrow in 42) were compared with those making only 1 marrow donation (n?=?5829). Experiences of second-time donors giving PBSCs (n?=?602) (first donation was PBSCs in 362; marrow in 240) were compared to first-time PBSC donors (n?=?16,095). For donors giving a second PBSC or marrow donation there were no significant differences in maximum skeletal pain, maximum symptoms measured by an established modified toxicity criteria, and recovery time compared with those who donated only once. Notably, the yield of marrow nucleated cells and PBSC CD34+ cells with second donations was less. As previously noted with single first-time donations, female (PBSCs and marrow) and obese donors (PBSCs) had higher skeletal pain and/or toxicity with a second donation. PBSC donors who experienced high levels of pain or toxicity with the first donation also experienced high levels of these symptoms with their second donation and slower recovery times. In conclusion, for most donors second donation experiences were similar to first donation experiences, but CD34+ yields were less. Knowledge of the donor's first experience and stem cell yields may help centers decide whether second donations are appropriate and institute measures to improve donor experiences. 相似文献
10.
Mohamed A. Kharfan-Dabaja Renju Raj Liana Nikolaenko Sairah Ahmed Nishitha Reddy Sunita Nathan Mohamad Cherry Najla El-Jurdi Cynthia Obiozor Timothy S. Fenske Joo Song Tariq Muzzafar Ernesto Ayala Bipin Savani Mohamad Khawandanah Paolo F. Caimi Mehdi Hamadani Stephen J. Forman Siddhartha Ganguly 《Biology of blood and marrow transplantation》2018,24(3):486-493
High-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) has been anecdotally prescribed in gray zone lymphoma (GZL), showing encouraging efficacy. We conducted a multicenter retrospective study aimed at assessing outcomes after auto-HCT in 32 patients with GZL treated at 9 transplantation centers in the United States. The median age of patients at transplantation was 38 years (range, 18 to 70 years), and the majority were male (n?=?21; 66%). The median number of lines of therapy before transplantation was 2 (range, 1 to 4). BEAM was the most commonly prescribed regimen (n?=?23; 72%). The median duration of follow-up for surviving patients was 34 months (range, 1 to 106 months). Median overall survival (OS) was not reached. The 3-year progression-free survival (PFS) and OS for all patients were 69% and 78%, respectively. Three-year PFS and OS were 100% for patients who received only 1 line of therapy before auto-HCT versus 65% (PFS, P?=?.25) and 75% (OS, P?=?.39) for those receiving >1 line. The cumulative incidence of relapse/progression was 4% at 1 year post-transplantation and 31% at 3 years post-transplantation. The 3-year nonrelapse mortality was 0%. These findings suggest that HDT and auto-HCT is an effective treatment in patients with GZL. Our findings ideally require confirmation in a larger cohort of patients, preferably in the setting of large prospective multicenter randomized controlled trials. However, we acknowledge that such studies could be difficult to conduct in patients with GZL owing to the disease's rarity. Alternatively, a multicenter prospective study that includes tissue banking and a data registry is warranted to help better understand the biology and natural history of the disease. 相似文献